{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T01:01:47Z","timestamp":1709427707873},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Clinical Pathology"],"published-print":{"date-parts":[[2005,6,1]]},"DOI":"10.1309\/kpxn-vr7x-4ame-nbbe","type":"journal-article","created":{"date-parts":[[2005,5,6]],"date-time":"2005-05-06T20:38:48Z","timestamp":1115411928000},"page":"826-832","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Usefulness of Aberrant CD22 Expression in Differentiating Neoplastic Cells of B-Cell Chronic Lymphoproliferative Disorders From Admixed Benign B Cells in Four-Color Multiparameter Flow Cytometry"],"prefix":"10.1093","volume":"123","author":[{"given":"James","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Gatter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Braziel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antony","family":"Bakke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"E00001","unstructured":"Deneys V, Mazzon AM, Marques JL, et al. Reference values for peripheral blood B-lymphocyte subpopulations: a basis for multiparametric immunophenotyping of abnormal lymphocytes. J Immunol Methods. 2001;253:23-36."},{"key":"E00002","unstructured":"Kawano-Yamamoto C, Muroi K, Izumi T, et al. Two-color flow cytometry with a CD19 gate for the evaluation of bone marrow involvement of B-cell lymphoma. Leuk Lymphoma. 2002;43:2133-2137."},{"key":"E00003","unstructured":"Reichard KK, McKenna RW, Kroft SH. Comparative analysis of light chain expression in germinal center cells and mantle cells of reactive lymphoid tissues: a four-color flow cytometric study. Am J Clin Pathol. 2003;119:130-136."},{"key":"E00004","unstructured":"Chizuka A, Kanda Y, Nannya Y, et al. The diagnostic value of kappa\/lambda ratios determined by flow cytometric analysis of biopsy specimens in B-cell lymphoma. Clin Lab Haematol. 2002;24:33-36."},{"key":"E00005","unstructured":"Samoszuk MK, Krailo M, Yan QH, et al. Limitations of numerical ratios for defining monoclonality of immunoglobulin light chains in B-cell lymphomas. Diagn Immunol. 1985;3:133-138."},{"key":"E00006","unstructured":"Fukushima PI, Nguyen PK, O'Grady P, et al. Flow cytometric analysis of kappa and lambda light chain expression in evaluation of specimens for B-cell neoplasia. Cytometry. 1996;26:243-252."},{"key":"E00007","unstructured":"Robbins BA, Ellison DJ, Spinosa JC, et al. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood. 1993;82:1277-1287."},{"key":"E00008","unstructured":"Sanchez ML, Almeida J, Vidriales B, et al. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Leukemia. 2002;16:1460-1469."},{"key":"E00009","unstructured":"Maddy AH, Sanderson A, Mackie MJ, et al. The role of cell maturation in the generation of phenotypic heterogeneity in B-cell chronic lymphocytic leukemia. Immunology. 1989;68:346-352."},{"key":"E00010","unstructured":"Rossmann ED, Lundin J, Lenkei R, et al. Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodies. Hematol J. 2001;2:300-306."},{"key":"E00011","unstructured":"Kehrl JH, Riva A, Wilson GL, et al. Molecular mechanisms regulating CD19, CD20 and CD22 gene expression. Immunol Today. 1994;15:432-436."},{"key":"E00012","unstructured":"Cesano A, Gayko U. CD22 as a target of passive immunotherapy. Semin Oncol. 2003;30:253-257."},{"key":"E00013","unstructured":"Viemann D, Schlenke P, Hammers HJ, et al. Differential expression of the B cell-restricted molecule CD22 on neonatal B lymphocytes depending upon antigen stimulation. Eur J Immunol. 2000;30:550-559."},{"key":"E00014","unstructured":"Chen J, McLean PA, Neel BG, et al. CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity. Nat Immunol. 2004;5:651-657."},{"key":"E00015","unstructured":"Siegel AB, Goldenberg DM, Cesano A, et al. CD22-directed monoclonal antibody therapy for lymphoma. Semin Oncol. 2003;30:457-464."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"deposited":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T15:09:01Z","timestamp":1447945741000},"score":1,"resource":{"primary":{"URL":"http:\/\/ajcp.metapress.com\/openurl.asp?genre=article&id=doi:10.1309\/KPXN-VR7X-4AME-NBBE"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,1]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6,1]]}},"alternative-id":["KPXNVR7X4AMENBBE"],"URL":"https:\/\/doi.org\/10.1309\/kpxn-vr7x-4ame-nbbe","relation":{},"ISSN":["0002-9173"],"issn-type":[{"value":"0002-9173","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6,1]]}}}